Contact Person : Andrea Weber; Last Date for the submission of abstract : Not Available ; Description : CEE, CIS together with SEE and Turkey represent attractive arenas for pharma companies due to the wide availability of untreated patients, insufficient access to preventive medicine as well as lower costs.